Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 18227842)

1.

Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

Li BE, Ernst P.

Exp Hematol. 2014 Dec;42(12):995-1012. doi: 10.1016/j.exphem.2014.09.006. Epub 2014 Sep 28. Review.

PMID:
25264566
2.

Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis.

Triviai I, Ziegler M, Bergholz U, Oler AJ, Stübig T, Prassolov V, Fehse B, Kozak CA, Kröger N, Stocking C.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8595-600. doi: 10.1073/pnas.1401215111. Epub 2014 May 27.

3.

Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.

Bard-Chapeau EA, Szumska D, Jacob B, Chua BQ, Chatterjee GC, Zhang Y, Ward JM, Urun F, Kinameri E, Vincent SD, Ahmed S, Bhattacharya S, Osato M, Perkins AS, Moore AW, Jenkins NA, Copeland NG.

PLoS One. 2014 Feb 27;9(2):e89397. doi: 10.1371/journal.pone.0089397. eCollection 2014.

4.

Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model.

Phaltane R, Haemmerle R, Rothe M, Modlich U, Moritz T.

Hum Gene Ther. 2014 Feb;25(2):144-55. doi: 10.1089/hum.2013.171. Epub 2014 Jan 7.

5.

EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.

Bard-Chapeau EA, Gunaratne J, Kumar P, Chua BQ, Muller J, Bard FA, Blackstock W, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2885-94. doi: 10.1073/pnas.1309310110. Epub 2013 Jul 15.

6.

Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability.

White DJ, Unwin RD, Bindels E, Pierce A, Teng HY, Muter J, Greystoke B, Somerville TD, Griffiths J, Lovell S, Somervaille TC, Delwel R, Whetton AD, Meyer S.

PLoS One. 2013 Jun 12;8(6):e66510. doi: 10.1371/journal.pone.0066510. Print 2013.

7.

Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cells.

Choudhary R, Baturin D, Fosmire S, Freed B, Porter CC.

PLoS One. 2013;8(3):e59594. doi: 10.1371/journal.pone.0059594. Epub 2013 Mar 15.

9.

Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity.

Kuether EL, Schroeder JA, Fahs SA, Cooley BC, Chen Y, Montgomery RR, Wilcox DA, Shi Q.

J Thromb Haemost. 2012 Aug;10(8):1570-80. doi: 10.1111/j.1538-7836.2012.04791.x.

10.

Stably integrated and expressed retroviral sequences can influence nuclear location and chromatin condensation of the integration locus.

Nagel J, Gross B, Meggendorfer M, Preiss C, Grez M, Brack-Werner R, Dietzel S.

Chromosoma. 2012 Aug;121(4):353-67. doi: 10.1007/s00412-012-0366-9. Epub 2012 Mar 14.

11.

Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.

Kebriaei P, Huls H, Jena B, Munsell M, Jackson R, Lee DA, Hackett PB, Rondon G, Shpall E, Champlin RE, Cooper LJ.

Hum Gene Ther. 2012 May;23(5):444-50. doi: 10.1089/hum.2011.167. Epub 2012 Jan 17.

12.

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain Mice.

Cai S, Wang H, Bailey B, Hartwell JR, Silver JM, Juliar BE, Sinn AL, Baluyut AR, Pollok KE.

Bone Marrow Res. 2011;2011:252953. doi: 10.1155/2011/252953. Epub 2010 Dec 26.

13.

Contributions of gene marking to cell and gene therapies.

Barese CN, Dunbar CE.

Hum Gene Ther. 2011 Jun;22(6):659-68. doi: 10.1089/hum.2010.237. Epub 2011 May 5. Review.

14.

Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Hu B, Tai A, Wang P.

Immunol Rev. 2011 Jan;239(1):45-61. doi: 10.1111/j.1600-065X.2010.00967.x. Review.

15.

Gene therapy of chronic granulomatous disease: the engraftment dilemma.

Grez M, Reichenbach J, Schwäble J, Seger R, Dinauer MC, Thrasher AJ.

Mol Ther. 2011 Jan;19(1):28-35. doi: 10.1038/mt.2010.232. Epub 2010 Nov 2. Review.

16.

Tracking of specific integrant clones in dogs treated with foamy virus vectors.

Ohmine K, Li Y, Bauer TR Jr, Hickstein DD, Russell DW.

Hum Gene Ther. 2011 Feb;22(2):217-24. doi: 10.1089/hum.2010.072. Epub 2010 Dec 19.

17.

Ex vivo expansion of retrovirally transduced primate CD34+ cells results in overrepresentation of clones with MDS1/EVI1 insertion sites in the myeloid lineage after transplantation.

Sellers S, Gomes TJ, Larochelle A, Lopez R, Adler R, Krouse A, Donahue RE, Childs RW, Dunbar CE.

Mol Ther. 2010 Sep;18(9):1633-9. doi: 10.1038/mt.2010.117. Epub 2010 Jun 22.

18.

Assessing the risk of T-cell malignancies in mouse models of SCID-X1.

Sorrentino B.

Mol Ther. 2010 May;18(5):868-70. doi: 10.1038/mt.2010.69. No abstract available.

19.

Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.

Métais JY, Topp S, Doty RT, Borate B, Nguyen AD, Wolfsberg TG, Abkowitz JL, Dunbar CE.

Gene Ther. 2010 Jun;17(6):799-804. doi: 10.1038/gt.2010.24. Epub 2010 Mar 18.

20.

Repetitive busulfan administration after hematopoietic stem cell gene therapy associated with a dominant HDAC7 clone in a nonhuman primate.

Xie J, Larochelle A, Maric I, Faulhaber M, Donahue RE, Dunbar CE.

Hum Gene Ther. 2010 Jun;21(6):695-703. doi: 10.1089/hum.2009.191.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk